Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

ADVERTISEMENT

SARAH: WHO’s first generative AI-based Tool for Health Promotion  

In order to harness generative AI for public health, WHO has launched SARAH (Smart AI Resource Assistant for Health), a digital health promoter to help people lead a healthier life. Available 24/7 in eight languages via video or text, SARAH provides information to people on distressful situations, heathy eating, quitting tobacco and e-cigarettes, road safety, and on several other areas of health. 

During COVID-19 pandemic, previous versions of digital health promoter were used under the name Florence to spread critical public health messages to people on the virus, vaccines, tobacco use, healthy eating and physical activity. Aimed to provide an additional tool for public to realize their rights to health, the latest version SARAH also provides up-to-date information on major health topics such as mental health, cancer, heart disease, lung disease, and diabetes.  

Compared to Florence, the new version provides more accurate and empathetic responses in real-time and engage with the users in dynamic personalized conversations that mirror human interactions. This has become possible because SARAH is powered by generative artificial intelligence (AI) rather than a pre-set algorithm. It uses new language models trained with the latest health information from the WHO and trusted partners and is supported by Biological AI of Soul Machines. Hence, it is more effective in supporting people in developing better understanding of risk factors for leading causes of death, including cancer, heart disease, lung disease, and diabetes.   

The improvised tool has potential to strengthen public health. However, the responses provided by SARAH to the users may not always be accurate because they are based on patterns and probabilities in the available data. It also raises important concerns about equitable access, privacy, safety and accuracy, data protection, and bias. The mission of bringing health information closer to the people requires continuous evaluation and refinement while maintaining the highest standards of ethics and evidence-based content.  

*** 

Sources: 

  1. WHO. News – WHO unveils a digital health promoter harnessing generative AI for public health. Posted 2 April 2024. Available at https://www.who.int/news/item/02-04-2024-who-unveils-a-digital-health-promoter-harnessing-generative-ai-for-public-health 
  1. About Sarah: WHO’s first digital health promoter https://www.who.int/campaigns/s-a-r-a-h 
  1. Biological AI. Soul Machines. Available at https://www.soulmachines.com/biological-ai  

*** 

SCIEU Team
SCIEU Teamhttps://www.scientificeuropean.co.uk
Scientific European® | SCIEU.com | Significant advances in science. Impact on humankind. Inspiring minds.

Subscribe to our newsletter

To be updated with all the latest news, offers and special announcements.

Most Popular Articles

MM3122: A lead Candidate for Novel Antiviral drug against COVID-19

TMPRSS2 is an important drug target to develop anti-viral...

Delivering Oral Dose of Insulin to Patients of Type 1 Diabetes: Trial Successful in...

A new pill has been designed which delivers insulin...

Nicotine’s Varying (Positive and Negative) Effects on the Brain

Nicotine has a vast array of neurophysiological effects, not...
- Advertisement -
93,060FansLike
47,191FollowersFollow
1,772FollowersFollow
30SubscribersSubscribe